JPH0251886B2 - - Google Patents

Info

Publication number
JPH0251886B2
JPH0251886B2 JP57092266A JP9226682A JPH0251886B2 JP H0251886 B2 JPH0251886 B2 JP H0251886B2 JP 57092266 A JP57092266 A JP 57092266A JP 9226682 A JP9226682 A JP 9226682A JP H0251886 B2 JPH0251886 B2 JP H0251886B2
Authority
JP
Japan
Prior art keywords
gastric
cytoprotective
lesions
solution
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57092266A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57209268A (en
Inventor
Aren Shuribaa Debitsudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of JPS57209268A publication Critical patent/JPS57209268A/ja
Publication of JPH0251886B2 publication Critical patent/JPH0251886B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment And Processing Of Natural Fur Or Leather (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
JP57092266A 1981-06-03 1982-06-01 Medicinal use of 16-methyl-1,11 alpha,16rs- trihydroxyprost-13e-en-9-one Granted JPS57209268A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/270,165 US4370348A (en) 1981-06-03 1981-06-03 Method of inducing cytoprotection

Publications (2)

Publication Number Publication Date
JPS57209268A JPS57209268A (en) 1982-12-22
JPH0251886B2 true JPH0251886B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-11-08

Family

ID=23030178

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57092266A Granted JPS57209268A (en) 1981-06-03 1982-06-01 Medicinal use of 16-methyl-1,11 alpha,16rs- trihydroxyprost-13e-en-9-one

Country Status (15)

Country Link
US (1) US4370348A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0066475B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS57209268A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880001028B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE22531T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU556621B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1171785A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3273533D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2101483B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (2) HK85186A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE54276B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY8700124A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ200680A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH17999A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG100287G (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675182A (en) * 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
US4470974A (en) * 1983-06-27 1984-09-11 Merck & Co., Inc. Gastric cytoprotection with L-363,586
US4681759A (en) * 1985-05-08 1987-07-21 Ortho Pharmaceutical Corporation Rioprostil-PVP complex
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
US6040132A (en) * 1996-06-14 2000-03-21 Biostore New Zealand, Ltd. Methods for the lyophilization of living biological materials
US6060233A (en) * 1996-06-14 2000-05-09 Biostore New Zealand, Ltd Methods for the lyophilization of platelets, platelet membranes or erythrocytes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132784A (en) * 1976-12-02 1979-01-02 The Dow Chemical Company (Substituted pyridyl)phenoxy phosphorus compounds and their use as insecticides
US4132738A (en) * 1978-02-23 1979-01-02 Miles Laboratories, Inc. Preparation of 15-deoxy-16-hydroxyprostaglandins

Also Published As

Publication number Publication date
PH17999A (en) 1985-02-28
CA1171785A (en) 1984-07-31
GB2101483B (en) 1986-03-12
ATE22531T1 (de) 1986-10-15
IE54276B1 (en) 1989-08-16
HK22088A (en) 1988-03-31
EP0066475A2 (en) 1982-12-08
KR830009776A (ko) 1983-12-23
GB2101483A (en) 1983-01-19
AU8442682A (en) 1982-12-09
DE3273533D1 (en) 1986-11-06
HK85186A (en) 1986-11-21
EP0066475B1 (en) 1986-10-01
SG100287G (en) 1988-09-30
AU556621B2 (en) 1986-11-13
EP0066475A3 (en) 1983-01-19
NZ200680A (en) 1984-11-09
US4370348A (en) 1983-01-25
JPS57209268A (en) 1982-12-22
MY8700124A (en) 1987-12-31
IE821328L (en) 1982-12-03
KR880001028B1 (ko) 1988-06-15

Similar Documents

Publication Publication Date Title
DK170889B1 (da) 9-halogen-prostanderivater og lægemidler indeholdende dem
SU1026652A3 (ru) Способ получени производных 9-хлорпростана или их солей
EP0059158B1 (de) Azaprostacycline, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
EP0310305B1 (en) Cathartics
JPS6344726B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5817746B2 (ja) シクロベンタンユウドウタイノ セイゾウホウホウ
US7459583B2 (en) Method for providing a cathartic effect
JPH0251886B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE2627673A1 (de) Prostaglandinartige 1,15-lactone sowie verfahren zu deren herstellung
US5817694A (en) 16-methyl-11,16-dihydroxy-9-oxoprost-2,13-dien-1-oic acid and derivatives
JPH0692362B2 (ja) 11―ハロゲン―プロスタン誘導体及びその製法
HU191057B (en) Process for the production of new carbacycline-derivatives and of the pharmaceutical preparations containing them
DE2638827A1 (de) Neue 11-deoxy-prostaglandine e, f tief alpha und f tief beta
HU192153B (en) Process for preparing carbacyclin amides and pharmaceutical compositions containing them
JPH02109A (ja) 下剤
EP0574185B1 (en) PGE1 analogs
DE2746932A1 (de) 5,9-cyclische aether von 9-deoxy- prostaglandin-f tief 1alpha -artigen verbindungen und verfahren zu deren herstellung
JPS59500471A (ja) 新規のカルバシクリン及びその製造法
US4576962A (en) Prostaglandin analogues
HU200601B (en) Process for producing 7-oxoprostacycline derivatives
JPH06505732A (ja) 新規なフェノールエーテル類、それらの製法およびそれらを含む薬剤
CA1255298A (en) Prostaglandin analogues
JPH06199779A (ja) トランス−▲δ2▼−15−デオキシ−16−ヒドロキシ−16−メチル−pg▲e1▼のメチルエステル(b−407)
HU206317B (en) Process for producing carbacyclines and pharmaceutical compositions containing them
JPH0643413B2 (ja) 7−オキソ−プロスタサイクリン誘導体、その製法および医薬組成物